These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37996391)

  • 1. Advances in Peptide-Decorated Targeted Drug Delivery: Exploring Therapeutic Potential and Nanocarrier Strategies.
    Buddhiraju HS; Yadav DN; Dey S; Eswar K; Padmakumar A; Rengan AK
    ACS Appl Bio Mater; 2024 Aug; 7(8):4879-4893. PubMed ID: 37996391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-Assisted Nucleic Acid Delivery Systems on the Rise.
    Tarvirdipour S; Skowicki M; Schoenenberger CA; Palivan CG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Anti-cancer Protein/Peptide Delivery.
    Liu X; Wu F; Ji Y; Yin L
    Bioconjug Chem; 2019 Feb; 30(2):305-324. PubMed ID: 30428665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
    Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
    Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembly of pH-sensitive fluorinated peptide dendron functionalized dextran nanoparticles for on-demand intracellular drug delivery.
    Ma S; Zhou J; Wali AR; He Y; Xu X; Tang JZ; Gu Z
    J Mater Sci Mater Med; 2015 Aug; 26(8):219. PubMed ID: 26238777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insight into the dual role of MoS2-based nanocarriers in anticancer drug delivery and therapy.
    Ghosh S; Lai JY
    Acta Biomater; 2024 Apr; 179():36-60. PubMed ID: 38552760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarrier Based Advances in Drug Delivery to Tumor: An Overview.
    Jain A; Kumari R; Tiwari A; Verma A; Tripathi A; Shrivastava A; Jain SK
    Curr Drug Targets; 2018; 19(13):1498-1518. PubMed ID: 29384060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy.
    Wickens JM; Alsaab HO; Kesharwani P; Bhise K; Amin MCIM; Tekade RK; Gupta U; Iyer AK
    Drug Discov Today; 2017 Apr; 22(4):665-680. PubMed ID: 28017836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.
    Wu W; Luo L; Wang Y; Wu Q; Dai HB; Li JS; Durkan C; Wang N; Wang GX
    Theranostics; 2018; 8(11):3038-3058. PubMed ID: 29896301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the Delivery of Chemotherapeutics: Role of Biodegradable Polymeric Nanoparticles.
    Ahlawat J; Henriquez G; Narayan M
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30150595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide Self-Assembled Nanocarriers for Cancer Drug Delivery.
    Kumar VB; Ozguney B; Vlachou A; Chen Y; Gazit E; Tamamis P
    J Phys Chem B; 2023 Mar; 127(9):1857-1871. PubMed ID: 36812392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges.
    Jiang Y; Yan C; Li M; Chen S; Chen Z; Yang L; Luo K
    Int J Biol Macromol; 2024 Oct; 278(Pt 4):135072. PubMed ID: 39191341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo targeted delivery of nanoparticles for theranosis.
    Koo H; Huh MS; Sun IC; Yuk SH; Choi K; Kim K; Kwon IC
    Acc Chem Res; 2011 Oct; 44(10):1018-28. PubMed ID: 21851104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer.
    Mukherjee D; Raikwar S
    AAPS PharmSciTech; 2024 Jul; 25(6):153. PubMed ID: 38961013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
    Mahajan K; Bhattacharya S
    Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancement of nanoscience in development of conjugated drugs for enhanced disease prevention.
    Taneja P; Sharma S; Sinha VB; Yadav AK
    Life Sci; 2021 Mar; 268():118859. PubMed ID: 33358907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy.
    Chary PS; Shaikh S; Rajana N; Bhavana V; Mehra NK
    Biomater Adv; 2024 Sep; 162():213903. PubMed ID: 38824828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Assembled Peptide Drug Delivery Systems.
    Yang J; An HW; Wang H
    ACS Appl Bio Mater; 2021 Jan; 4(1):24-46. PubMed ID: 35014275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.